A report on the Liquid Biopsy Market has been recently published by Stratview Research. This Market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the Liquid Biopsy Market. The historic years considered for the study are 2013-2018 the base year is 2019, and the forecast period is 2019-2025

The study includes an in-depth analysis of type, application, and regional segments. It also includes a Market channel, distribution, and customer analysis, industry cost analysis, Market analysis by application, production, revenue, and price trend analysis by type, production and consumption analysis by region, and various other Market studies.

Market Analysis

Liquid Biopsy Market is likely to witness a steady CAGR of over 18.0%, during the forecast period. Major factors such as increase in the number of cancer patients, increasing demand for non-invasive treatment procedures, and growing awareness about the benefits of liquid biopsy are expected to drive the growth of the market during the forecast period. Furthermore, liquid biopsy offers advantages such as low cost, rapid and accurate results, and early detection of diseases, all of which are expected to fuel the market’s growth during the forecast period.

The Market is segmented by Products & Services Type (Assay Kits, Instruments, and Services), by Application Type (Cancer {Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, and Others} and Non-Cancer), by Clinical Application Type (Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Early Cancer Screening), by Circulating Biomarkers Type (Circulating Tumor Cells, Cell-Free DNA, Circulating Tumor DNA, Extracellular Vesicles, and Others), by Technology Type (Multi-Gene Parallel Analysis Using NGS and Single-Gene Analysis Using PCR Microarrays), by End-User Type (Reference Laboratories, Hospitals and Physician Laboratories, Academic & Research Centers, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

This report also focuses on the short- and long-term implications of the novel Coronavirus pandemic on Liquid Biopsy Market at the global, and regional dimensions. To evaluate the percentage of loss or profit to the industry, the report also compares pre-COVID and post-COVID scenarios.

Report Features

The report delivers a detailed view of the industry based on Liquid Biopsy Market size, Market growth, and opportunities. The report also analyses Market key aspects such as-

–           Market structure: Overview, industry life cycle analysis, supply chain analysis

–           Covid-19 Impact analysis.

–           Market environment analysis: Growth drivers and constraints, and SWOT analysis.

–           Market trend and forecast analysis.

–           Market segment trend and forecast.

–           Competitive landscape and dynamics: Market share, product launches, etc.

–           Attractive Market segments and associated growth opportunities.

–           Emerging trends.

–           Strategic growth opportunities for the existing and new players.

The research provides in-depth analysis of the important elements that drive Market growth, including growth potential, opportunities, current Market trends, industry-specific obstacles, and dangers.

Key Segments Liquid Biopsy Market Report Covers:

Based on the application type, the market is segmented as cancer and non-cancer applications. Cancer application is further sub-segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, melanoma, and others. The cancer segment is likely to grow significantly at an exponential CAGR, during the forecast period, largely due to the increasing number of cancer cases and increasing demand for liquid biopsy for diagnosis. In addition, the increasing number of research studies on liquid biopsy for cancer application is further expected to drive the growth of the market during the forecast period.

Based on the technology type, the market is segmented as multi-gene parallel analysis using NGS and single-gene analysis using PCR microarrays. Between these two technology types, the single-gene analysis using PCR microarrays segment is expected to be dominant in the market over the forecast period. The segment’s growth can be attributed to the use of PCR, which is increasing due to its increasing use for various purposes, including detecting fungal infections, bacterial infections, gene mapping, and other genomic applications. PCR tests’ quick and real-time diagnostic results are accurate, and they can guide targeted therapies for cancer treatment. PCR is rapidly gaining popularity and is expected to grow at a rapid pace in the coming years.

Based on the end-user type, the market is segmented as reference laboratories, hospitals and physician laboratories, academic & research centers, and others. Reference laboratories are expected to be the dominant segment of the market during the forecast period. The outsourcing of liquid biopsy tests to reference laboratories is expected to drive the market growth over the forecast period.

In terms of regions, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. Among these regions, Asia-Pacific is expected to be the fastest-growing region in the market during the forecast period. The region is distinguished by rising disposable income, increasing healthcare expenditure, growing awareness of liquid biopsy techniques, and rising adoption of advanced diagnostic techniques in hospitals, clinics, and diagnostic laboratories. The growing penetration of hospitals and diagnostic centers in the region is likely to bolster the growth of the market over the forecast period. North America and Europe are also expected to offer substantial growth opportunities during the forecast period.

According to the report, brands or companies that are leading globally in this Market are –

  • Biocept Inc.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • MDxHealth SA
  • Thermo Fisher Scientific Inc.

Report Customization –

This report can be customized to meet the client’s obligations. Please get along with our sales team (sales@stratviewresearch.com), who will ensure that you get a report that fits your needs. You can also touch a chord with our executives on +1-313-307-4176 to share your research constraints.

About Us –

Stratviewresearch.com is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. Stratview Research possesses a global presence to enable current Market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. We survey clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.